Scientists around St. Louis worry their medical research will lose key funding as the National Institutes of Health (NIH) announced changes on how finance grants can be ...

Andrew Spaventa, the Chief Executive Officer of Singular Genomics Systems , Inc. (NASDAQ:OMIC), recently sold 800 shares of the company's common stock, totaling $15,912. The shares were sold at an ...

Through new partnerships with industry leaders, Nvidia aims to help advance practical use cases for AI in healthcare and life ...

China has put Illumina on its ‘unreliable entity list’ after the US imposed sanctions on Beijing Genomics Institute, also a ...

Genomics is bringing in a new wave of money from an unlikely group of investors — health systems. More providers are ...

Genomics reported a Q4 EPS loss of $(0.40), missing estimates, while revenue declined 10% year over year. Analysts lowered price targets amid profitability concerns.

Biomedical engineers at Duke University have demonstrated a promising new approach that could be used to treat a rare and ...

Gene therapy represents a paradigm shift in modern medicine, offering unprecedented opportunities to combat diseases at their ...

Researchers have successfully uncovered the molecular mechanisms by which bacterial cellulose patches stimulate the regeneration of plant wounds.   - The regeneration process requires the activation ...

Following an international search, Professor Cristóbal Uauy has been appointed as the next Director of the John Innes Centre.